Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33M
-
Number of holders
-
279
-
Total 13F shares, excl. options
-
28M
-
Shares change
-
-1.69M
-
Total reported value, excl. options
-
$2.7B
-
Value change
-
-$154M
-
Put/Call ratio
-
7.52
-
Number of buys
-
111
-
Number of sells
-
-147
-
Price
-
$96.51
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q3 2024
342 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q3 2024.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 279 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28M shares
of 33M outstanding shares and own 84.83% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.21M shares), BlackRock, Inc. (3.07M shares), FARALLON CAPITAL MANAGEMENT LLC (1.5M shares), FIL Ltd (1.31M shares), Westchester Capital Management, LLC (1.12M shares), Pentwater Capital Management LP (1.08M shares), STATE STREET CORP (951K shares), ALPINE ASSOCIATES MANAGEMENT INC. (861K shares), MACKENZIE FINANCIAL CORP (695K shares), and ALLIANCEBERNSTEIN L.P. (664K shares).
This table shows the top 279 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.